Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-26-000089

Executive Chair sold 26,759 shares at $72.00 ($1,926,648)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SAYER KEVIN R Executive Chair 2026-05-21 Sale 10b5-1 −26,759 $72.00 $1,926,648 382,482 D: show line 1 in the form
Open-market sales · 26,759 sh · avg $72.00 · $1,926,648
Loading xslF345X06/wk-form4_1779826702.xml…